Item Details

Print View

Drugs and Biologics [electronic resource]: Hearings Before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, First Session, May 25, 1995-a Consumer's Perspective, June 19, 1995-FDA Review Process

United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations
Format
Online; EBook; Government Document
Published
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1995.
Language
English
Series
ProQuest U.S. Congressional Hearings Digital Collection
SuDoc Number
Y 4.C 73/8:104-23
Description
iii, 175 p. : ill. ; 24 cm.
System requirements: PDF reader software.
Notes
  • Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
  • Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
  • CIS No. HRG-1995-COH-0010
  • Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC.
Reproduction Notes
Electronic reproduction. [Bethesda, Md.] : ProQuest, 2004. digital, PDF file. ProQuest U.S. Congressional Hearings Digital Collection. Mode of access: World Wide Web via ProQuest website.
Copyright Not EvaluatedCopyright Not Evaluated
Technical Details
  • Staff View

    LEADER 02839nam a22003731a 4500
    001 cis2007464552
    006 m d f
    007 cr bn mmmapmmp
    008 091024s1995 dcua s f000 0 eng d
    043
      
      
    a| n-us---
    074
      
      
    a| 1019-A-01
    074
      
      
    a| 1019-B-01 (MF)
    086
    0
      
    a| Y 4.C 73/8:104-23
    088
      
      
    a| Serial no. 104-23 (United States. Congress. House. Committee on Commerce)
    110
    1
      
    a| United States. b| Congress. b| House. b| Committee on Commerce. b| Subcommittee on Oversight and Investigations.
    245
    1
    0
    a| Drugs and biologics h| [electronic resource] : b| hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995-a consumer's perspective, June 19, 1995-FDA review process.
    260
      
      
    a| Washington : b| U.S. G.P.O. : b| For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, c| 1995.
    300
      
      
    a| iii, 175 p. : b| ill. ; c| 24 cm.
    500
      
      
    a| Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
    500
      
      
    a| Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
    500
      
      
    a| CIS No. HRG-1995-COH-0010
    500
      
      
    a| Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC.
    533
      
      
    a| Electronic reproduction. b| [Bethesda, Md.] : c| ProQuest, d| 2004. e| digital, PDF file. n| ProQuest U.S. Congressional Hearings Digital Collection. n| Mode of access: World Wide Web via ProQuest website.
    538
      
      
    a| System requirements: PDF reader software.
    610
    1
    0
    a| United States. b| Food and Drug Administration.
    650
      
    0
    a| Drugs x| Bioavailability z| United States.
    650
      
    0
    a| Drugs x| Testing x| Health aspects z| United States.
    650
      
    0
    a| Drugs x| Testing x| Economic aspects z| United States.
    776
    0
    8
    i| Print version: a| United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations. t| Drugs and biologics w| (OCoLC)33215258 w| (DGPO)96059723
    776
    0
    8
    i| Microfiche version: a| United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations. t| Drugs and biologics. d| [Bethesda, Md.] : ProQuest,[2004] o| CIS 95 H271-19 w| (ProQuest)cis09500282
    830
      
    0
    a| ProQuest U.S. Congressional Hearings Digital Collection.
    856
    4
    0
    u| http://proxy.its.virginia.edu/login?url=http://congressional.proquest.com/congcomp/getdoc?HEARING-ID=HRG-1995-COH-0010 y| Electronic resource (PDF)
    998
      
      
    a| cis09500282
    040
      
      
    a| UMI c| UMI
▾See more
▴See less

Availability

Read Online